1. Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending directive 2001/83/EC and regulation (EC) No 726/2004. The Official Journal of the European Union2007.
2. Committee for Advanced Therapies. EMA warns against using unproven cell-based therapies EMA/CAT/94295/2020. Amsterdam: European Medicines Agency; 2020.
3. Hettle R, Corbett M, Hinde S, Hodgson R, Jones-Diette J, Woolacott N, et al. The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal. Health Technol Assess. 2017;21(7):1–204.
4. National Institute for Health and Care Excellence. Reviewing our methods for health technology evaluation: consultation. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/chte-methods-consultation. Cited 12 Dec 2020.
5. National Institute for Health and Care Excellence. Guidance and advice list. https://www.nice.org.uk/guidance/published?type=hst. Cited 12 Dec 2020